<h1>US Exempts Pharmaceuticals From New 27% Reciprocal Tariffs on India, Boosting Pharma Company Shares</h1> Pharmaceutical company shares rose significantly after the Trump administration exempted pharmaceuticals from new reciprocal tariffs. Jubilant Pharmova led gains with a 6.82% increase, followed by Ipca Laboratories (5.26%), Lupin (4.26%), and Sun Pharmaceutical Industries (3.26%). Several other pharma stocks also posted gains despite the broader market declining. The US announced 27% reciprocal tariffs on India but excluded pharmaceuticals and essential items, recognizing the importance of generic medicines globally. The Indian Pharmaceutical Alliance noted this exemption highlights the critical role of these medications.